|
π
|
Novel antisense oligonucleotides targeting TGF-Ξ² inhibit in vivo scarring and improve surgical outcome
10 auth.
M. Cordeiro,
A. Mead,
R. Ali,
R. Alexander,
S. Murray,
C. Chen,
...
C. York-Defalco,
NM Dean,
G. Schultz,
P. Khaw
|
7 |
2003 |
7
π
|
|
π’
|
AAV-mediated gene therapy for retinal disorders: from mouse to man
PK Buch,
J. Bainbridge,
R. Ali
|
6 |
2008 |
6
π’
|
|
π’
|
Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors
10 auth.
K. Balaggan,
K. Binley,
M. Esapa,
S. Iqball,
Z. Askham,
O. Kan,
...
M. Tschernutter,
J. Bainbridge,
S. Naylor,
R. Ali
|
6 |
2006 |
6
π’
|
|
π’
|
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus
7 auth.
G. Sarra,
C. Stephens,
F. Schlichtenbrede,
J. Bainbridge,
A. Thrasher,
P. Luthert,
...
R. Ali
|
5 |
2002 |
5
π’
|
|
π¦
|
Co-injection of adenovirus expressing CTLA4-Ig prolongs adenovirally mediated lacZ reporter gene expression in the mouse retina
8 auth.
R. Ali,
M. Reichel,
A. Byrnes,
C. Stephens,
A. Thrasher,
D. Baker,
...
D. Hunt,
S. Bhattacharya
|
4 |
1997 |
4
π¦
|
|
π’
|
Improvement of neuronal visual responses in the superior colliculus in Prph2
Rd2/Rd2 mice following gene therapy
F. Schlichtenbrede,
A. Smith,
J. Bainbridge,
A. Thrasher,
T. Salt,
R. Ali
|
3 |
2004 |
3
π’
|
|
π’
|
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
13 auth.
A. Georgiadis,
Y. DurΓ‘n,
J. Ribeiro,
L. Abelleira-Hervas,
S. Robbie,
B. SΓΌnkel-Laing,
S. Fourali,
A. Gonzalez-Cordero,
E. Cristante,
M. Michaelides,
...
J. Bainbridge,
A. Smith,
R. Ali
|
1 |
2018 |
1
π’
|
